Literature DB >> 23660860

Components of the revised International Prognostic Scoring System and outcome after hematopoietic cell transplantation for myelodysplastic syndrome.

Aaron T Gerds, Ted A Gooley, Wendy A Wilson, H Joachim Deeg.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23660860      PMCID： PMC3650710          DOI： 10.1182/blood-2013-02-486118

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

1.  Revised international prognostic scoring system for myelodysplastic syndromes.

Authors:  Peter L Greenberg; Heinz Tuechler; Julie Schanz; Guillermo Sanz; Guillermo Garcia-Manero; Francesc Solé; John M Bennett; David Bowen; Pierre Fenaux; Francois Dreyfus; Hagop Kantarjian; Andrea Kuendgen; Alessandro Levis; Luca Malcovati; Mario Cazzola; Jaroslav Cermak; Christa Fonatsch; Michelle M Le Beau; Marilyn L Slovak; Otto Krieger; Michael Luebbert; Jaroslaw Maciejewski; Silvia M M Magalhaes; Yasushi Miyazaki; Michael Pfeilstöcker; Mikkael Sekeres; Wolfgang R Sperr; Reinhard Stauder; Sudhir Tauro; Peter Valent; Teresa Vallespi; Arjan A van de Loosdrecht; Ulrich Germing; Detlef Haase
Journal:  Blood       Date:  2012-06-27       Impact factor: 22.113

2.  International scoring system for evaluating prognosis in myelodysplastic syndromes.

Authors:  P Greenberg; C Cox; M M LeBeau; P Fenaux; P Morel; G Sanz; M Sanz; T Vallespi; T Hamblin; D Oscier; K Ohyashiki; K Toyama; C Aul; G Mufti; J Bennett
Journal:  Blood       Date:  1997-03-15       Impact factor: 22.113

3.  Clinical effect of point mutations in myelodysplastic syndromes.

Authors:  Rafael Bejar; Kristen Stevenson; Omar Abdel-Wahab; Naomi Galili; Björn Nilsson; Guillermo Garcia-Manero; Hagop Kantarjian; Azra Raza; Ross L Levine; Donna Neuberg; Benjamin L Ebert
Journal:  N Engl J Med       Date:  2011-06-30       Impact factor: 91.245

4.  Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS.

Authors:  H Joachim Deeg; Bart L Scott; Min Fang; Howard M Shulman; Boglarka Gyurkocza; David Myerson; John M Pagel; Uwe Platzbecker; Aravind Ramakrishnan; Jerald P Radich; Brenda M Sandmaier; Mohamed Sorror; Derek L Stirewalt; Wendy A Wilson; Rainer Storb; Frederick R Appelbaum; Ted Gooley
Journal:  Blood       Date:  2012-07-05       Impact factor: 22.113

5.  Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.

Authors:  Luca Malcovati; Elli Papaemmanuil; David T Bowen; Jacqueline Boultwood; Matteo G Della Porta; Cristiana Pascutto; Erica Travaglino; Michael J Groves; Anna L Godfrey; Ilaria Ambaglio; Anna Gallì; Matteo C Da Vià; Simona Conte; Sudhir Tauro; Norene Keenan; Ann Hyslop; Jonathan Hinton; Laura J Mudie; James S Wainscoat; P Andrew Futreal; Michael R Stratton; Peter J Campbell; Eva Hellström-Lindberg; Mario Cazzola
Journal:  Blood       Date:  2011-10-12       Impact factor: 22.113

6.  Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome.

Authors:  H Joachim Deeg; Barry Storer; John T Slattery; Claudio Anasetti; Kristine C Doney; John A Hansen; Hans-Peter Kiem; Paul J Martin; Effie Petersdorf; Jerald P Radich; Jean E Sanders; Howard M Shulman; Edus H Warren; Robert P Witherspoon; Eileen M Bryant; Thomas R Chauncey; Lisa Getzendaner; Rainer Storb; Frederick R Appelbaum
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

7.  Allogeneic bone marrow transplantation for myelodysplastic syndrome: outcomes analysis according to IPSS score.

Authors:  F R Appelbaum; J Anderson
Journal:  Leukemia       Date:  1998-09       Impact factor: 11.528

8.  Elevated lactate dehydrogenase is an adverse predictor of outcome in HLA-matched sibling bone marrow transplant for acute myelogenous leukemia.

Authors:  M Kalaycio; L Rybicki; B Pohlman; R Dean; J Sweetenham; S Andresen; R Sobecks; M A Sekeres; A Advani; S Brown; B Bolwell
Journal:  Bone Marrow Transplant       Date:  2007-08-13       Impact factor: 5.483

9.  New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge.

Authors:  Julie Schanz; Heinz Tüchler; Francesc Solé; Mar Mallo; Elisa Luño; José Cervera; Isabel Granada; Barbara Hildebrandt; Marilyn L Slovak; Kazuma Ohyashiki; Christian Steidl; Christa Fonatsch; Michael Pfeilstöcker; Thomas Nösslinger; Peter Valent; Aristoteles Giagounidis; Carlo Aul; Michael Lübbert; Reinhard Stauder; Otto Krieger; Guillermo Garcia-Manero; Stefan Faderl; Sherry Pierce; Michelle M Le Beau; John M Bennett; Peter Greenberg; Ulrich Germing; Detlef Haase
Journal:  J Clin Oncol       Date:  2012-02-13       Impact factor: 44.544
  9 in total
  2 in total

Review 1.  Molecular Data and the IPSS-R: How Mutational Burden Can Affect Prognostication in MDS.

Authors:  Aziz Nazha; Rafael Bejar
Journal:  Curr Hematol Malig Rep       Date:  2017-10       Impact factor: 3.952

Review 2.  Improving Prognostic Modeling in Myelodysplastic Syndromes.

Authors:  Aziz Nazha; Mikkael A Sekeres
Journal:  Curr Hematol Malig Rep       Date:  2016-12       Impact factor: 3.952
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.